Amid the industrial prosperity and favorable policies, China’s production-use plasma volume broke through 4,000 tons and the total lot release volume jumped by 15% year on year to 52.4 million bottles in 2014. By lot release volume, human albumin, human rabies immunoglobulin, human immunoglobulin (ph4) for intravenous injection and tetanus immunoglobulin were the most popular blood products in China in 2014, accounting for 59.8%, 14.6%, 13.6% and 4.1% of the total lot release volume respectively. Browse Full Report With TOC @ http://www.researchmoz.us/china-blood-product-industry-report-2015-2018-report.html
http://www.researchmoz.us/china-blood-product-industry-report-2015-2018-report.html
No comments:
Post a Comment